Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

Genprex, Inc. · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
gene-therapy
small cell lung cancer extensive stage, atezolizumab, atezolizumab and hyaluronidase-tqjs, tumor suppressor gene 2 (tusc2), lipid nanoparticle (lnp), gene therapy, tecentriq, es-sclc, reqorsa, quaratusugene ozeplasmid, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 862357
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.